Investment company Innovassynth Technologies (India) announced Q1FY27 results Financial Highlights: Total Income: For Q1FY27, the company reported a Total Income of Rs 5,617.74 lakh, an increase of 10.27% QoQ from Rs 5,094.66 lakh in Q4FY26 and a 354.61% YoY increase from a restated Rs 1,235.72 lakh in Q1FY26. Revenue from Operations: Revenue for Q1FY27 stood at Rs 5,598.59 lakh, reflecting a growth of 10.15% QoQ compared to Rs 5,082.67 lakh in Q4FY26 and a 356.21% YoY rise from a restated Rs 1,227.21 lakh in Q1FY26. Profit Before Tax (PBT): The company achieved a PBT of Rs 1,115.61 lakh in Q1FY27, representing a significant growth of 431.47% QoQ from Rs 209.91 lakh in Q4FY26 and a turnaround from a restated loss of Rs 1,875.34 lakh in Q1FY26. Net Profit (Profit after Tax): For Q1FY27, the company reported a Net Profit of Rs 673.53 lakh, showing a 43.64% decrease QoQ from Rs 1,195.13 lakh in Q4FY26 and a turnaround from a restated net loss of Rs 1,867.36 lakh in Q1FY26. Total Comprehensive Income: This stood at Rs 673.53 lakh in Q1FY27, compared to Rs 1,210.27 lakh in Q4FY26 and a restated total comprehensive loss of Rs 1,867.36 lakh in Q1FY26. Earnings Per Share (EPS): Basic and Diluted EPS for Q1FY27 was Rs 0.80, compared to Rs 1.58 in Q4FY26 and a restated negative Rs 2.47 in Q1FY26. Annual Performance (FY26): For the full year FY26, the company reported Total Income of Rs 10,295.93 lakh, Revenue from Operations of Rs 10,235.21 lakh, and a Net Loss of Rs 2,878.80 lakh. Business Highlights: Completion of Merger: The company successfully completed the merger of Innovassynth Technologies (India) Limited ("ITIL") into Innovassynth Investments Limited. Following the merger, the name was changed to Innovassynth Technologies (India) Limited. The comparative figures for Q1FY26 have been restated to include the impact of this merger. Rights Issue Allotment: During the quarter, on May 19, 2026, the company completed the allotment of 1,74,11,380 equity shares on a rights basis at a price of Rs 40 per share, aggregating to Rs 6,964.55 lakh. Segment Information: The company's primary business is the manufacturing of specialty chemicals and pharmaceutical intermediates. Management has noted that all other operating activities are incidental to this main business, and therefore, there are no separate reportable segments. Labour Code Impact: The company previously assessed an incremental impact of Rs 80.94 lakh for FY26 due to the consolidation of new labour codes in India, primarily arising from changes in the definition of wages and recognition of past service costs. Result PDF